35
Participants
Start Date
April 13, 2010
Primary Completion Date
July 8, 2013
Study Completion Date
July 8, 2013
Replagal
0.2 mg/kg administered intravenously \[IV\] every other week
General Hospital Slovenj Gradec, Slovenj Gradec
The Royal Melbourne Hospital, Parkville
O&O Alpan LLC, Fairfax
University of Iowa Hospitals and Clinics, Iowa City
1st School of Medicine Charles University, Prague
Instytut Kardiologii, I Klinika Choroby Wiencowej, Warsaw
Turku University Central Hospital, Turku
Szpital Uniwersytecki w Krakowie, Krakow
Salford Royal NHS Foundation Trust, Salford
Lead Sponsor
Shire
INDUSTRY